"Piperacillin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
| Descriptor ID |
D010878
|
| MeSH Number(s) |
D02.065.589.099.750.750.050.650 D02.886.108.750.750.050.650 D03.633.100.300.750.750.050.650
|
| Concept/Terms |
Piperacillin Sodium- Piperacillin Sodium
- Sodium, Piperacillin
- Piperacillin Monosodium Salt
- Monosodium Salt, Piperacillin
- Salt, Piperacillin Monosodium
AB-Piperacillin- AB-Piperacillin
- AB Piperacillin
- Piperacillin Curasan
- Curasan, Piperacillin
|
Below are MeSH descriptors whose meaning is more general than "Piperacillin".
Below are MeSH descriptors whose meaning is more specific than "Piperacillin".
This graph shows the total number of publications written about "Piperacillin" by people in this website by year, and whether "Piperacillin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Piperacillin" by people in Profiles.
-
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. JAMA. 2023 05 09; 329(18):1579-1588.
-
Antimicrobial Susceptibility of Elizabethkingia Species: Report from a Reference Laboratory. J Clin Microbiol. 2022 06 15; 60(6):e0254121.
-
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model. J Antimicrob Chemother. 2020 05 01; 75(5):1228-1236.
-
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016 05 18; 8(339):339ra71.
-
Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam. Surg Infect (Larchmt). 2012 Feb; 13(1):38-42.
-
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains. Scand J Infect Dis. 2010 Jul; 42(6-7):506-9.
-
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect. 2008 Jan; 14 Suppl 1:181-4.
-
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother. 2006 Jun; 50(6):2244-7.
-
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother. 2005 Nov; 49(11):4555-60.
-
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study. Infect Dis Obstet Gynecol. 2003; 11(1):27-37.